Novel Microdevices, Inc. Awarded ~$1.4M from NIH RADx® Tech to Develop a Next-generation, High Performance, Point-of-Care RT-PCR Test.
Fulton Bank, an Important Growth Engine for Regional Life Sciences Companies
Published on :In 2019, Fulton Bank launched a new division aimed at supporting life sciences companies that many financial institutions shied away from historically—young, emerging bioscience and tech companies that offer high risk, high reward investment profiles.
CARB-X is Funding Baltimore’s Novel Microdevices to Develop a Rapid and Portable Diagnostic for STDs Including Antibiotic-Resistant Infections
Published on :CARB-X is funding Novel Microdevices to develop a rapid and portable diagnostic for sexually transmitted diseases including antibiotic-resistant infections New portable battery-powered diagnostic is designed to be easy-to-use in any setting around [….]